Vivos Therapeutics, Inc. (VVOS)
0.1428
+0.01
(+6.57%)
USD |
NASDAQ |
Oct 15, 16:00
0.1356
-0.01
(-5.04%)
After-Hours: 20:00
Vivos Therapeutics Cash from Operations (TTM) : -17.13M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.13M |
| March 31, 2026 | -17.48M |
| December 31, 2025 | -15.26M |
| September 30, 2025 | -14.39M |
| June 30, 2025 | -14.42M |
| March 31, 2025 | -13.97M |
| December 31, 2024 | -12.69M |
| September 30, 2024 | -12.50M |
| June 30, 2024 | -11.11M |
| March 31, 2024 | -10.92M |
| Date | Value |
|---|---|
| December 31, 2023 | -11.95M |
| September 30, 2023 | -12.20M |
| June 30, 2023 | -15.24M |
| March 31, 2023 | -17.04M |
| December 31, 2022 | -19.59M |
| September 30, 2022 | -20.71M |
| June 30, 2022 | -18.93M |
| March 31, 2022 | -17.96M |
| December 31, 2021 | -15.74M |
| September 30, 2021 | -15.23M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Hinge Health, Inc. | 290.79M |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | 0.1175M |
| Pro-Dex, Inc. | 7.242M |
| Autonomix Medical, Inc. | -13.16M |